Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus

Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus

Show other versions (2)

Objective: To analyze the effects of treatment approach on the outcomes of newborns (birth weight [BW] < 1,000 g) with patent ductus arteriosus (PDA), from the Brazilian Neonatal Research Network (BNRN) on: death, bronchopulmonary dysplasia (BPD), severe intraventricular hemorrhage (IVH III/IV),...

Full description

Bibliographic Details
Main Authors:	Lilian S.R. Sadeck, Cléa R. Leone, Renato S. Procianoy, Ruth Guinsburg, Sergio T.M. Marba, Francisco E. Martinez, Ligia M.S.S. Rugolo, M. Elisabeth L. Moreira, Renato M. Fiori, Ligia L. Ferrari, Jucille A. Menezes, Paulyne S. Venzon, Vânia Q.S. Abdallah, José Luiz M.B. Duarte, Marynea V. Nunes, Leni M. Anchieta, Navantino Alves Filho
Format:	Article
Language:	Portuguese
Published:	Brazilian Society of Pediatrics 2014-11-01
Series:	Jornal de Pediatria (Versão em Português)
Subjects:	Preterm Very low birth weight Ligation PDA management
Online Access:	http://www.sciencedirect.com/science/article/pii/S225555361400127X

Similar Items

Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus
by: Lilian S.R. Sadeck, et al.
Published: (2014-11-01)

Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus
by: Lilian S.R. Sadeck, et al.
Published: (2014-12-01)

Ligation of patent ductus arteriosus in very low birth weight premature infants
by: Hasan F. Othman, et al.
Published: (2020-08-01)

Conservative Management of Patent Ductus Arteriosus in Preterm Infants—A Systematic Review and Meta-Analyses Assessing Differences in Outcome Measures Between Randomized Controlled Trials and Cohort Studies
by: Tim Hundscheid, et al.
Published: (2021-02-01)

Prophylaxis of Patent Ductus Arteriosus with Paracetamol in Extremely Low Gestational Age Newborns (ELGANs): A Single-Institution Observational Study in Vietnam
by: Tinh Thu Nguyen, et al.
Published: (2023-12-01)

Correlation between the Closure Time of Patent Ductus Arteriosus in Preterm Infants and Long-Term Neurodevelopmental Outcome
by: Natsumi Kikuchi, et al.
Published: (2024-01-01)

Left ventricular dysfunction postsurgical patent ductus arteriosus ligation in children: predictor factors analysis
by: Mohamed Abdel-Bary, et al.
Published: (2019-09-01)

Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021-02-01)

Gentamicin in neonates with hemodynamically significant patent ductus arteriosus
by: Kannan Sridharan, et al.
Published: (2023-01-01)

Modern treatment of patent ductus arteriosus – single center experience
by: Senka Mesihović Dinarević, et al.
Published: (2014-12-01)

Ductus arteriosus aneursym causing hoarseness which is the best treatment option; surgery or endovascular?
by: Namık Ozmen
Published: (2016-09-01)

Device closure of patent ductus arteriosus in interrupted inferior vena cava
by: Neeraj Aggarwal, et al.
Published: (2015-12-01)

Transcatheter device closure of patent ductus arteriosus without arterial access – Single institution experience
by: Gaurav Garg, et al.
Published: (2013-09-01)

Evaluating the Clinical Course of Patent Ductus Arteriosus after Discharge and Comparing in Therapies Techniques
by: Noor Mohammad Noori, et al.
Published: (2017-05-01)

Patent Ductus Arteriosus (P.D.A.) (An analysis of 37 surgically proved cases)
by: O. J. Rachman, et al.
Published: (2019-09-01)

Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data
by: Flaminia Bardanzellu, et al.
Published: (2020-12-01)

The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study
by: Josephat M. Chinawa, et al.
Published: (2021-03-01)

Evaluation of Alacepril Administration in Canine Patent Ductus Arteriosus According to Plasma Chymase Activity
by: Kazumi Shimada, et al.
Published: (2024-04-01)

REVERSE PDA – LESS COMMON TYPE OF PATENT DUCTUS ARTERIOSUS -CASE REPORT
by: Iuliu Scurtu, et al.
Published: (2016-11-01)

Should we “eliminate” PDA shunt in preterm infants? A narrative review
by: Aimann Surak, et al.
Published: (2024-02-01)

The effects of WeChat follow-up management to improve the parents’ mental status and the quality of life of premature newborns with patent ductus arteriosus
by: Bin Yang, et al.
Published: (2021-08-01)

Premature infants with patent ductus arteriosus: Postnatal growth according to type of management
by: Kunal Babla, et al.
Published: (2021-01-01)

Stent implantation into ductus arteriosus: a new alternative of palliative treatment of duct-dependent pulmonary circulation
by: Mulyadi M Djer, et al.
Published: (2016-10-01)

Personalized Evidence-Based Management of Patent Ductus Arteriosus in Preterm Infants
by: Belinda Chan, et al.
Published: (2023-12-01)

Management of Patent Ductus Arteriosus in Term or Near-term Neonates With Respiratory Distress
by: Yu-Chen Lin, et al.
Published: (2010-06-01)

Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants
by: Yogen Singh, et al.
Published: (2020-11-01)

Transport and Anaesthesia Consideration for Transcatheter Patent Ductus Arteriosus Closure in Premature Infants
by: Tuan Chen Aw, et al.
Published: (2023-09-01)

Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure
by: Feng JQ, et al.
Published: (2016-11-01)

Myocardial injury and inflammatory response in percutaneous device closures of pediatric patent ductus arteriosus
by: Zeng-Rong Luo, et al.
Published: (2022-05-01)

Respiratory Trajectory after Invasive Interventions for Patent Ductus Arteriosus of Preterm Infants
by: Yu-Jen Wei, et al.
Published: (2021-05-01)

The Amplatzer duct occluder (ADOII) and Piccolo devices for patent ductus arteriosus closure: a large single institution series
by: Elchanan Bruckheimer, et al.
Published: (2023-05-01)

Paracetamol-responsive patent ductus arteriosus in a late preterm very low birth weight neonate at 4 weeks postnatal age
by: Amitoj Singh Chhina, et al.
Published: (2016-01-01)

Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates
by: Aparna Patra, et al.
Published: (2021-02-01)

Patent Ductus Arteriosus Device Closure with AMPLATZER Duct Occluder-II in a Low Birth Weight Preterm Neonate- First Experience in Pakistan
by: Sana Imtiaz, et al.
Published: (2023-05-01)

Transthoracic minimally invasive occlusion of a large patent ductus arteriosus with irreversible thrombocytopenia: A case report
by: Wenjun Zhou, et al.
Published: (2023-11-01)

Surgical management of patent ductus arteriosus in pre-term infants - a british paediatric surveillance study
by: A. Warnock, et al.
Published: (2021-06-01)

Patent ductus arteriosus in a Nigerian adult: A case report and overview of treatment modalities
by: Ismail Mohammed Inuwa, et al.
Published: (2022-01-01)

Anesthesia protocols for “bedside” preterm patent ductus arteriosus ligation: A single-institutional experience
by: Reena Khantwal Joshi, et al.
Published: (2021-01-01)

Efficacy and safety of transcarotid compared to transfemoral approach of patent ductus arteriosus stenting in duct-dependent cyanotic heart disease
by: Made Satria Yudha Dewangga, et al.
Published: (2023-06-01)

Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams
by: Alain Fraisse, et al.
Published: (2020-09-01)